Article
Evaluation of Secretome Biomarkers in Glioblastoma Cancer Stem Cells: A Bioinformatics Analysis
2024-04-01
Abstract excerpt
Glioblastoma (GBM) is a malignant brain tumor that frequently occurs alongside other central nervous systems (CNS) conditions. Glutamate release and aberrant cellular behavior are shared features of both CNS diseases and GBM cells. Neither their origin nor the ways in which CNS disorders affect the development or behavior of GBM are well understood. Using data from the Gene Expression Omnibus (GEO) and the Cancer...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- a7962fdb-30f3-5513-b190-2a04db6f798b
- DOI
- 10.22541/au.171196300.02993557/v1
